EditRegion7
SCIENTIFIC PROGRAM

DAY 1 Sessions

  • Opening Session and Welcome
  • 1. Genetics and Population Studies -
              Global Health
  • 2. Pathogenesis and Imaging
  • 3. The Egyptian Society of Cardiology Session

DAY 2 Sessions

  • 1. Imaging
  • 2. Management
  • 3. Primary PCI
  • 4. Primary PCI (2)

DAY 3 Sessions

  • Ask the Experts. Challenging
            case presentations by young interventionists
Preliminary Program
DAY 1
  • OPENING SESSION

    +

    Welcome and course objectives (Magdi Yacoub) Time of transition: from bench and bedside to community, from disease prevention to health promotion and from industrialized to underprivileged nations (Valentin Fuster)

  • SESSION 1 - GENETICS AND POPULATION STUDIES (1)

    +

    Genetics of CAD: from risk stratification to basic mechanisms ( E Topol/ R Roberts)
    Global Cardiovascular Disease: insights from INTERHEART (Salim Yusuf) Framingham: what have we learnt from the last 5 decades? (Daniel Levy). The UK Biobank Study of 500,000 people: rationale and design (Rory Collins/ Chris O’Connel)
    The 1000genomes Study: why map global genetic diversity? (Goncalo Abecasis/ Mike Boehnke/ David Altshuler)

  • SESSION 2 - GENETICS AND POPULATION STUDIES (2)

    +

    The LOLIPOP Study: insights into ethnicity (Jaspal Kooner) The Global Epidemic of Diabetes and Obesity: what do we learn from genomics? (Mark McCarthy/ Tim Frayling/ Philippe Froguel)
    Personalized Medicine: bringing genomics to the bedside (John Todd/ Francis Collins/ Stuart Cook)
    Gulf ACS study (Jassem Al-Sewedi)
    The Evolving Aswan Program (Ahmed ElGuindy)

    KEYNOTE ADDRESS
    From Atoms to Medicine (Ahmed Zewail)

  • SESSION 3 – PATHOGENESIS AND IMAGING (1)

    +

    - Plaque Rupture is the ONLY Culprit (Erling Falk)
    - Plaque Composition (Val F’s advice)
    - Do Not Forget Erosions (Virmani)
    - A Role for the Immune System and Inflammation? (Finnish/Peter Libby)
    - Heart Rate: The Forgotten Link in CAD (Kim Fox)

  • SESSION 4 – PATHOGENESIS AND IMAGING (2)

    +

    - Coagulation (Valentin Fuster)
    - Subcellular Targets & Molecular Targeting (Zahi Fayad)
    - Designing Strategies for Imaging (Jagat Narula)
    - IVUS and OCT: ready for routine use? (Carlo DiMario)





DAY 2
  • SESSION 1 - MANAGEMENT (1)

    +

    Algorithms for management and risk stratification (Donald Lloyd Jones)
    Biomarkers; what’s new? (Anna Dominiczak or James de Lemos)
    Dousing the plaques pharmacologically (P Shah/ Val F’s advice)
    New antiplatelet agents (Deepak Bhatt)
    Predicting efficacy (Val F’s advice?)
    Vaccine (Nielsen

  • SESSION 2 - MANAGEMENT (2)

    +

    Imaging: Added value or added cost (Robert Bonow)
    Multislice CT; when can it be useful? (Pim De Feyter?)
    Mechanical restraints and interventions (Patrick Serruys)

  • SESSION 3 – PRIMARY PCI (1)

    +

    Setting up a primary PCI service (David Antoniucci)
    Lessons from Europe; Stent for life program (Carlo DiMario?)
    Designing trials with an eye on the world (Patrick Serruys)
    Egypt and primary PCI – (Mohamed Sobhy)

  • SESSION 4 – PRIMARY PCI (2)

    +

    Good old and new stents (Ulrich Sigwart)
    Rheolytic therapy and thrombus aspiration: What is the evidence? (David Antoniucci)
    Beyond epicardial coronaries; role of the microcirculation (Roxy Senior)
    Surgery: when and for whom? (David Taggart)

    KEYNOTE ADDRESS
    Future of ACS management (Eugene Braunwald)